The DAWN Antivirals Trial for Ambulatory COVID-19 Patients

NCT04730206 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
44
Enrollment
OTHER
Sponsor class

Stopped recruitment was too slow

Conditions

Interventions

Sponsor

KU Leuven

Collaborators